Skip to Navigation
Skip to Main Content
Skip to Related Content

U.S. markets closed

S&P 500
4,411.79
+44.31(+1.01%)
Dow 30
35,061.55
+238.20(+0.68%)
Nasdaq
14,836.99
+152.39(+1.04%)
Russell 2000
2,209.65
+10.17(+0.46%)
Crude Oil
72.17
+0.26(+0.36%)
Gold
1,802.10
-3.30(-0.18%)

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

182.41+0.60 (+0.33%)

At close: 4:00PM EDT

182.41 0.00 (0.00%)
After hours: 04:36PM EDT

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Inside Bar (Bearish)

Inside Bar (Bearish)

View all chart patterns

Performance Outlook

Previous Close	181.81
Open	182.00
Bid	167.58 x 3100
Ask	185.04 x 800
Day's Range	180.11 - 183.46
52 Week Range	119.29 - 184.83
Volume	512,283
Avg. Volume	632,533

Market Cap	21.441B
Beta (5Y Monthly)	1.23
PE Ratio (TTM)	N/A
EPS (TTM)	-7.55
Earnings Date	Aug 03, 2021
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	174.78

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

All

Research Reports

Business Wire
Alnylam to Webcast Conference Call Discussing Second Quarter 2021 Financial Results
CAMBRIDGE, Mass., July 21, 2021--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the second quarter ending June 30, 2021 on Tuesday, August 3, 2021, before the U.S. financial markets open.
- Ironwood Pharmaceuticals to Host Second Quarter 2021 Investor Update Call
  Business Wire
- PLx Pharma Inc. to Discuss 2021 Second Quarter Financial Results on August 6, 2021 Conference Call and Provide Business Update
  GlobeNewswire
Investor's Business Daily
Alnylam Pharmaceuticals Stock Sees Healthy Rising Relative Strength Rating
A Relative Strength Rating upgrade for Alnylam Pharmaceuticals shows improving technical performance. Will it continue?
- Floor & Decor Sees RS Rating Rise To 82, Becomes An IBD Stock To Watch
  Investor's Business Daily
- Editas Medicine Stock Shows Improved Relative Strength Rating
  Investor's Business Daily
Insider Monkey
Hedge Funds Aren’t Crazy About Alnylam Pharmaceuticals, Inc. (ALNY) Anymore
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F filings […]